“HRT” is often used as a catch-all term, but hormone therapy looks very different depending on whether it is used for menopause-related symptoms in women or for clinically confirmed low testosterone in men. The hormones, goals, eligibility, dosing approach, and risk profile are not the same, which is why treatment decisions should be individualized and guided by a qualified clinician.
Below is a clear comparison of how hormone replacement therapy typically differs for women and men.
What HRT Usually Means For Women
For women, “HRT” most often refers to menopausal hormone therapy (MHT), which uses estrogen (and sometimes a progestogen) to treat symptoms related to perimenopause and menopause. A major goal is symptom relief for issues like hot flashes and night sweats, as well as vaginal and urinary symptoms, and it can also help prevent bone loss in appropriate candidates.
Estrogen Alone Vs Estrogen Plus Progestogen
A key difference for women is whether they have a uterus:
- If a woman still has a uterus, estrogen is usually paired with a progestogen because unopposed estrogen increases the risk of endometrial (uterine) cancer.
- If a woman has had a hysterectomy, estrogen may be used alone, depending on her clinical situation. ACOG
Symptom Focus And Timing
The North American Menopause Society (NAMS) notes that hormone therapy remains the most effective treatment for vasomotor symptoms (hot flashes) and that risks vary based on factors like type, dose, route, and timing of initiation. NAMS also states that for many women younger than 60 or within 10 years of menopause onset, the benefit-risk ratio is generally more favorable when there are no contraindications.
What HRT Usually Means For Men
For men, “HRT” most often refers to testosterone replacement therapy (TRT) for men with hypogonadism, meaning they have both:
- Symptoms consistent with low testosterone, and
- Consistently low testosterone levels confirmed by testing.
The Endocrine Society guideline emphasizes diagnosing hypogonadism only in men who meet both criteria and then using testosterone therapy appropriately with monitoring.
Not A General Anti-Aging Treatment
The FDA labeling for testosterone products includes a “Limitation of Use” related to age-related hypogonadism and continues to refine safety messaging based on newer data, including the TRAVERSE trial. This matters because it reinforces that TRT is intended for specific medical indications, not simply for feeling “older” or wanting a performance boost.
Different Goals: Symptom Relief Vs Hormone Deficiency Treatment
Women’s menopause hormone therapy is often aimed at:
- Reducing hot flashes and night sweats
- Improving vaginal dryness and genitourinary symptoms
- Supporting bone health in appropriate patients
Men’s testosterone therapy is often aimed at:
- Treating symptoms of hypogonadism in men with documented low levels
- Improving sexual function symptoms in appropriate candidates
- Supporting related clinical outcomes under medical supervision
Different Hormones And Formulations
Women
Menopause hormone therapy may use:
- Systemic estrogen (pills, patches, gels, sprays) for broader symptoms like hot flashes
- Local vaginal estrogen for vaginal and urinary symptoms, with much lower systemic exposure
- If the uterus is present, a progestogen is typically added for endometrial protection.
Men
Testosterone therapy may use:
- Gels, patches, injections, or other FDA-approved formulations
The choice often depends on preference, cost, absorption, and how stable levels need to be.
Different Monitoring And Safety Concerns
Monitoring In Women
Monitoring typically focuses on:
- Symptom response and side effects
- Ongoing reassessment of the benefit-risk balance, especially as duration changes
- Whether a progestogen is needed to protect the uterus
Cancer risk discussions are also different depending on whether therapy is estrogen-only or combined estrogen-progestin, and whether a uterus is present.
Monitoring In Men
Monitoring often includes:
- Confirming testosterone levels reach an appropriate range
- Checking hematocrit due to the risk of erythrocytosis (too many red blood cells)
- Prostate-related monitoring and shared decision-making in appropriate age groups and risk profiles
The FDA also requires labeling updates related to blood pressure effects for some products and includes updated cardiovascular safety information informed by newer trials.
Fertility Considerations Are Not The Same
- Men: Testosterone therapy can suppress sperm production and is generally not used as a fertility treatment. This is an important discussion point for men who want children. (Your clinician can review alternatives if fertility is a priority.)
- Women: Menopausal hormone therapy is not designed to preserve fertility, and it is not a contraceptive plan. It is used to manage symptoms and related health goals during and after the menopausal transition.
How To Think About “Right Fit”
A practical way to frame the difference:
- Women’s HRT (MHT) is often about relieving menopause-related symptoms and improving quality of life, with decisions shaped by uterus status, symptom type, age, timing, and individual risk factors.
- Men’s HRT (TRT) is typically about treating a clinically defined hormone deficiency with confirmed lab findings and symptoms, with careful monitoring for blood and prostate-related factors.
Summary
HRT differs for women and men because it treats different clinical situations. In women, HRT usually means menopausal hormone therapy using estrogen, and often a progestogen if the uterus is present to reduce endometrial cancer risk. In men, HRT usually means testosterone therapy for hypogonadism, which requires both symptoms and consistently low testosterone confirmed by testing, plus ongoing monitoring for safety. In both cases, the safest approach is individualized care with regular reassessment of benefits, risks, and goals.
If you are searching for HRT, consider Xplore Health’s hormone replacement in Roseville.
